Mia's Feed
Medical News & Research

Genetic Mutation Linked to Severe Paralysis After Mild Infections in Children

Genetic Mutation Linked to Severe Paralysis After Mild Infections in Children

Share this article

Research has uncovered a genetic mutation in the RCC1 gene that causes severe nerve damage and paralysis in children following mild infections, offering new hope for diagnosis and treatment.

2 min read

Scientists at the University of Manchester have identified a genetic condition that causes children to develop severe nerve damage and paralysis following mild infections. Their research revealed that mutations in the RCC1 gene are responsible for this unusual and devastating response. The study, titled "Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants," analyzed cases from multiple countries, including the UK, Turkey, Czechia, Germany, Iran, India, Saudi Arabia, Cyprus, and Slovakia. Among the cases studied, children experienced rapid nerve deterioration after infections such as flu or respiratory illnesses, which are typically mild. For example, Timothy Bingham, who first lost the ability to walk at age two after a flu, and an 8-month-old girl who required ventilator support after a chest infection, exemplify this condition. The research team conducted laboratory experiments on patient skin cells and genetically engineered fruit flies, demonstrating that chemical damage observed in nerve cells resembles conditions like motor neuron disease and Guillain-Barré syndrome. These findings not only elucidate the genetic cause behind these severe nerve reactions but also open avenues for early diagnosis and potential treatments. The discovery offers hope for at-risk children, suggesting that interventions could be implemented before nerve damage occurs. Experts emphasize that understanding this genetic link may also provide insights into more common nerve disorders, helping to develop targeted therapies. The study underscores the importance of genetic testing in children presenting with unexplained nerve weakness after mild infections and marks a significant step toward managing rare neurodegenerative conditions in pediatric populations.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Kenya Achieves Milestone in Public Health by Eliminating Sleeping Sickness, According to WHO

Kenya has been declared free from sleeping sickness as a public health problem by the WHO, marking a major milestone in the fight against this parasitic disease in Africa.

Innovative Radiotracer Promises Faster and More Precise Breast Cancer Detection

A groundbreaking radiotracer developed at the University of Alberta offers faster, more accurate breast cancer detection through targeted imaging and rapid results, with potential therapeutic applications on the horizon.